fda warns hims & hers for selling unapproved compounded semaglutide launched a $49 weight loss pill last week, offering a version of semaglutide, the active ingredient in approved drugs like Wegovy. Just 48 hours later, the company Hims & Hers launches Wegovy
Description
Diabetes Nutrition & Wellness | American Diabetes Association [Internet]
Retatrutide showed a 7% discontinuation rate at the 12mg dose, while Mounjaro demonstrated a 6% discontinuation rate at 15mg
Future work should prioritize MASLD-specific cardiovascular risk models that integrate liver fibrosis severity, CMRFs, and biomarkers, and that are externally validated across diverse race/ethnicities and regions
persistent concerns should be discussed with a healthcare professional
